Neal Franklin Fowler
CIK 1493692 · Chief Executive Officer · last filed 2026-05-04
Neal Franklin Fowler is a Chief Executive Officer who has filed 20 SEC Form 4 insider transactions across 4 companies since 2010. The most recent filing, for EBS, was dated May 4, 2026. Across all open-market trades the lifetime net is −$204.1K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $6.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$6.93M
4
20
-$204.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EBS | Director | 160,847 | $8.32 | $1.34M | -$204.1K | 5 | 2026-05-04 |
| LQDA | Chief Executive Officer | 78,512 | $71.23 | $5.59M | $0 | 1 | 2020-11-20 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Director | 73,869 | — | — | $0 | 4 | 2017-05-12 |
| POZEN INC /NC (POZN) Delisted | Director | 52,774 | — | — | $0 | 6 | 2015-07-30 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-04 | EBS | Grant (A) | +25,344 | $0 | EDGAR |
| 2025-05-02 | EBS | Grant (A) | +34,403 | $0 | EDGAR |
| 2025-03-12 | EBS | Sell (S) | −35,000 | -$204.1K | EDGAR |
| 2024-05-28 | EBS | Grant (A) | +17,430 | $0 | EDGAR |
| 2023-10-05 | EBS | Grant (A) | +118,670 | $0 | EDGAR |
| 2020-11-20 | LQDA | Mixed | +27,201 | -$5.0K | EDGAR |
| 2020-03-20 | — | Grant (A) | +30,400 | $0 | |
| 2019-02-07 | — | Grant (A) | — | $0 | |
| 2018-10-16 | — | Grant (A) | +11,238 | $0 | |
| 2018-07-27 | — | Grant (A) | — | $0 |